Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers

Japanese Journal of Cancer Research

Volumn 93, Issue 10, 2002, Pages 1114-1122

  Watanabe, Takafumi ^a,b   Imoto, Issei ^a   Katahira, Tomoyuki ^c   Hirasawa, Akira ^a   Ishiwata, Isamu ^d   Emi, Mitsuru ^e   Takayama, Masaomi ^f   Sato, Akira ^b   Inazawa, Johji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^d Lshiwata Obstetrics and Gynecologic Hospitallsh   (Japan)

^e NIPPON MEDICAL SCHOOL   (Japan)

^f TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

20q; Amplification; Ovarian cancer

Indexed keywords

DNA; HOMEODOMAIN PROTEIN; REPRESSOR PROTEIN; TGIF2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; ZNF217 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CENTROMERE; CHROMOSOME 20Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; NORTHERN BLOTTING; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; CHROMOSOME 20; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; OVARY TUMOR;

CHROMOSOMES, HUMAN, PAIR 20; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; OVARIAN NEOPLASMS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0036807853     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01213.x     Document Type: Article

References (45)

1. Pejovic, T. Genetic changes in ovarian cancer. Ann. Med., 27, 73-78 (1995).
2. Iwabuchi, H., Sakamoto, M., Sakunaga, H., Ma, Y. Y., Carcangiu, M. L., Pinkel, D., Yang-Feng, T. L. and Gray, J. W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res., 55, 6172-6180 (1995).
3. Arnold, N., Hagele, L., Walz, L., Schempp, W., Pfisterer, J., Bauknecht, T. and Kiechle, M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosom. Cancer, 16, 46-54 (1996).
4. Sonoda, G., Palazzo, J., du Manoir, S., Godwin, A. K., Feder, M., Yakushiji, M. and Testa, J. R. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosom. Cancer, 20, 320-328 (1997).
5. Watanabe, T., Imoto, I., Kosugi, Y., Ishiwata, I., Inoue, S., Takayama, M., Sato, A. and Inazawa, J. A novel amplification at 17q21-23 in ovarian cancer cell lines detected by comparative genomic hybridization. Gynecol. Oncol., 81, 172-177 (2001).
6. Kallioniemi, A., Kallioniemi, O. P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S., Pinkel, D., Gray, J. W. and Waldman, F. M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA, 91, 2156-2160 (1994).
7. Ried, T., Knutzen, R., Steinbeck, R., Blegen, H., Schrock, E., Heselmeyer, K., du Manoir, S. and Auer, G. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosom. Cancer, 15, 234-245 (1996).
8. Ghadimi, B. M., Schrock, E., Walker, R. L., Wangsa, D., Jauho, A., Meltzer, P. S. and Ried, T. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am. J. Pathol., 154, 525-536 (1999).
9. Tanner, M. M., Tirkkonen, M., Kallioniemi, A., Holli, K., Collins, C., Kowbel, D., Gray, J. W., Kallioniemi, O. P. and Isola, J. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin. Cancer Res., 1, 1455-1461 (1995).
10. Korn, W. M., Yasutake, T., Kuo, W. L., Warren, R. S., Collins, C., Tomita, M., Gray, J. and Waldman, F. M. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosom. Cancer, 25, 82-90 (1999).
11. Tanner, M. M., Grenman, S., Koul, A., Johannsson, O., Meltzer, P., Pejovic, T., Borg, A. and Isola, J. J. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res., 56, 3441-3445 (1996).
12. Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W. L., Chen, C., Zhai, Y., Dairkee, S. H., Ljung, B. M., Gray, J. W. and Albertson, D. G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet., 20, 207-211 (1998).
13. Saito, M., Helin, K., Valentine, M. B., Griffith, B. B., Willman, C. L., Harlow, E. and Look, A. T. Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia. Genomics, 25, 130-138 (1995).
14. Guan, X. Y., Xu, J., Anzick, S. L., Zhang, H., Trent, J. M. and Meltzer, P. S. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res., 56, 3446-3450 (1996).
15. Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X. Y., Sauter, G., Kallioniemi, O. P., Trent, J. M. and Meltzer, P. S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science, 277, 965-968 (1997).
16. Sen, S., Zhou, H. and White, R. A. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene, 14, 2195-2200 (1997).
17. Collins, C., Rommens, J. M., Kowbel, D., Godfrey, T., Tanner, M., Hwang, S. I., Polikoff, D., Nonet, G., Cochran, J., Myambo, K., Jay, K. E., Froula, J., Cloutier, T., Kuo, W. L., Yaswen, P., Dairkee, S., Giovanola, J., Hutchinson, G. B., Isola, J., Kallioniemi, O. P., Palazzolo, M., Martin, C., Ericsson, C., Pinkel, D., Albertson, D., Li, W. B. and Gray, J. W. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc. Natl. Acad. Sci. USA, 95, 8703-8708 (1998).
18. Imoto, I., Pimkhaokham, A., Watanabe, T., Saito-Ohara, F., Soeda, E. and Inazawa, J. Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE super-class, in ovarian cancer cell lines. Biochem. Biophys. Res. Commun., 276, 264-270 (2000).
19. Tanner, M. M., Grenman, S., Koul, A., Johannsson, O., Meltzer, P., Pejovic, T., Borg, A. and Isola, J. J. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin. Cancer Res., 6, 1833-1839 (2000).
20. Collins, C., Volik, S., Kowbel, D., Ginzinger, D., Ylstra, B., Cloutier, T., Hawkins, T., Predki, P., Martin, C., Wernick, M., Kuo, W. L., Alberts, A. and Gray, J. W. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res., 11, 1034-1042 (2001).
21. Imoto, I., Pimkhaokham, A., Fukuda, Y., Yang, Z. Q., Shimada, Y., Nomura, N., Hirai, H., Imamura, M. and Inazawa, J. SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem. Biophys. Res. Commun., 286, 559-565 (2001).
22. Imoto, I., Yang, Z. Q., Pimkhaokham, A., Tsuda, H., Shimada, Y., Imamura, M., Ohki, M. and Inazawa, J. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res., 61, 6629-6634 (2001).
23. Inazawa, J., Saito, H., Ariyama, T., Abe, T. and Nakamura, Y. High-resolution cytogenetic mapping of 342 new cosmid markers including 43 RFLP markers on human chromosome 17 by fluorescence in situ hybridization. Genomics, 17, 153-162 (1993).
24. Bassi, C., Magnani, I., Sacchi, N., Saccone, S., Ventura, A., Rocchi, M., Marozzi, A., Ginelli, E. and Meneveri, R. Molecular structure and evolution of DNA sequences located at the alpha satellite boundary of chromosome 20. Gene, 256, 43-50 (2000).
25. Wittwer, C. T., Herrmann, M. G., Moss, A. A. and Rasmussen, R. P. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques, 22, 130-138 (1997).
26. Goff, L. K., Neat, M. J., Crawley, C. R., Jones, L., Jones, E., Lister, T. A. and Gupta, R. K. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma. Br. J. Haematol., 111, 618-625 (2000).
27. Yasui, K., Arii, S., Zhao, C., Imoto, I., Ueda, M., Nagai, H., Emi, M. and Inazawa, J. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology, 35, 1476-1484 (2002).
28. Barlund, M., Monni, O., Kononen, J., Cornelison, R., Torhorst, J., Sauter, G., Kallioniemi, O. P. and Kallioniemi, A. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res., 60, 5340-5344 (2000).
29. Wu, G. J., Sinclair, C. S., Paape, J., Ingle, J. N., Roche, P. C., James, C. D. and Couch, F. J. 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes. Cancer Res., 60, 5371-5375 (2000).
30. Monni, O., Barlund, M., Mousses, S., Kononen, J., Sauter, G., Heiskanen, M., Paavola, P., Avela, K., Chen, Y., Bittner, M. L. and Kallioniemi, A. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc. Natl. Acad. Sci. USA, 98, 5711-5716 (2001).
31. Wu, G., Sinclair, C., Hinson, S., Ingle, J. N., Roche, P. C. and Couch, F. J. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors. Cancer Res., 61, 4951-4955 (2001).
32. Racz, A., Brass, N., Heckel, D., Pahl, S., Remberger, K. and Meese, E. Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma. Eur. J. Cancer, 35, 641-646 (1999).
33. Sattler, H. P., Lensch, R., Rohde, V., Zimmer, E., Mese, E., Bonkhoff, H., Retz, M., Zwergel, T., Bex, A., Stoeckle, M. and Wullich, B. Novel amplification unit at chromosome 3q25-q27 in human prostate cancer. Prostate, 45, 207-215 (2000).
34. Redon, R., Muller, D., Caulee, K., Wanherdrick, K., Abecassis, J. and du Manoir, S. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res., 61, 4122-4129 (2001).
35. Platzer, P., Upender, M. B., Wilson, K., Willis, J., Lutterbaugh, J., Nosrati, A., Willson, J. K. V., Mack, D., Ried, T. and Markowitz, S. Silence of chromosomal amplifications in colon cancer. Cancer Res., 62, 1134-1138 (2002).
36. Fujii, T., Dracheva, T., Player, A., Chacko, S., Clifford, R., Strausberg, R. L., Buetow, K., Azumi, N., Travis, W. D. and Jen, J. A preliminary transcriptome map of non-small cell lung cancer. Cancer Res., 62, 3340-3346 (2002).
37. Sato, K., Qian, J., Slezak, J. M., Lieber, M. M., Bostwick, D. G., Bergstralh, E. J. and Jenkins, R. B. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J. Natl. Cancer. Inst., 91, 1574-1580 (1999).
38. Hidaka, S., Yasutake, T., Takeshita, H., Kondo, M., Tsuji, T., Nanashima, A., Sawai, T., Yamaguchi, H., Nakagoe, T., Ayabe, H. and Tagawa, Y. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin. Cancer Res., 6, 2712-2717 (2000).
39. Nonet, G. H., Stampfer, M. R., Chin, K., Gray, J. W., Collins, C. C. and Yaswen, P. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res., 61, 1250-1254 (2001).
40. Melhuish, T. A., Gallo, C. M. and Wotton, D. TGIF2 interacts with histone deacetylase 1 and represses transcription. J. Biol. Chem., 276, 32109-32114 (2001).
41. Wiener, J. R., Kerns, B. J., Harvey, E. L., Conaway, M. R., Iglehart, J. D., Berchuck, A. and Bast, R. C., Jr. Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression. J. Natl. Cancer Inst., 86, 372-378 (1994).
42. Wiener, J. R., Hurteau, J. A., Kerns, B. J., Whitaker, R. S., Conaway, M. R., Berchuck, A. and Bast, R. C., Jr. Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. Am. J. Obstet. Gynecol., 170, 1177-1183 (1994).
43. Sakakura, C., Hagiwara, A., Yasuoka, R., Fujita, Y., Nakanishi, M., Masuda, K., Kimura, A., Nakamura, Y., Inazawa, J., Abe, T. and Yamagishi, H. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int. J. Cancer, 89, 217-223 (2000).
44. Zhou, H., Kuang, J., Zhong, L., Kuo, W. L., Gray, J. W., Sahin, A., Brinkley, B. R. and Sen, S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet., 20, 189-193 (1998).
45. Sakakura, C., Hagiwara, A., Yasuoka, R., Fujita, Y., Nakanishi, M., Masuda, K., Shimomura, K., Nakamura, Y., Inazawa, J., Abe, T. and Yamagishi, H. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br. J. Cancer, 84, 824-831 (2001).